Type 2 & other diabetes

Blood pressure and adverse cardiovascular outcomes in older people with type 2 diabetes and chronic kidney disease: Findings based on the Clinical Practice Research Datalink databases in England

Diabetes Obes MetabPublished Retrospective cohort study

Authors' conclusion

In older adults with T2D and CKD, lower SBP and DBP were moderately associated with a higher risk of MACE and mortality, but the strongest indicator of adverse outcomes was the absence of regular blood pressure monitoring.

Study context

Population
Adults aged ≥65 with both T2D and chronic kidney disease (CKD), Clinical Practice Research Datalink (CPRD), EnglandMajor adverse cardiovascular events (MACE) analysis
Participants
160,764 adults
Exposure
Baseline SBP categories: high vs normal vs missing
Outcome
MACE:
  • Nonfatal stroke
  • MI
  • Cardiovascular death
Follow-up
5-year
Methodological detailsClinical Practice Research Datalink (CPRD) data, flexible parametric competing risks models
  • Clinical Practice Research Datalink (CPRD) data
  • Flexible parametric competing risks models

Main finding

As reported in the abstract

Adjusted 5-year MACE risk by SBP

Observational data: associations, not effects.

Secondary outcomes

All-cause mortality (5-year risk)

  • All-cause mortality (5-year risk): mortality analysis included 181 307

All-cause mortality (5-year risk)

Lower SBP (120 mmHg) moderately associated with increased mortality; higher DBP (90 mmHg) linked to increased mortality

SBP vs DBP as risk indicator

SBP was a stronger risk indicator than DBP for both outcomes

Sex differences

Men had higher MACE and mortality risks than women

Original publication

Blood pressure and adverse cardiovascular outcomes in older people with type 2 diabetes and chronic kidney disease: Findings based on the Clinical Practice Research Datalink databases in England. Diabetes Obes Metab. Published 28 October 2025. doi:10.1111/dom.70234

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.